XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series A Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Series C Redeemable Convertible Preferred Stock
Series D Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2018 $ (57,728)         $ 6 $ 1,339 $ (59,073)
Beginning balance, shares at Dec. 31, 2018   6,225,719 6,786,896 3,688,740        
Beginning balance at Dec. 31, 2018   $ 24,967 $ 55,151 $ 37,692        
Beginning balance, shares at Dec. 31, 2018           3,757,403    
Vesting of early exercised stock options 20           20  
Stock-based compensation expense 266           266  
Net loss (13,671)             (13,671)
Ending balance at Mar. 31, 2019 (71,113)         $ 6 1,625 (72,744)
Ending balance, shares at Mar. 31, 2019   6,225,719 6,786,896 3,688,740        
Ending balance at Mar. 31, 2019   $ 24,967 $ 55,151 $ 37,692        
Ending balance, shares at Mar. 31, 2019           3,757,403    
Beginning balance at Dec. 31, 2018 $ (57,728)         $ 6 1,339 (59,073)
Beginning balance, shares at Dec. 31, 2018   6,225,719 6,786,896 3,688,740        
Beginning balance at Dec. 31, 2018   $ 24,967 $ 55,151 $ 37,692        
Beginning balance, shares at Dec. 31, 2018           3,757,403    
Exercise of stock options (in shares) 280,836              
Net loss $ (35,653)              
Ending balance at Sep. 30, 2019 (92,160)         $ 7 2,559 (94,726)
Ending balance, shares at Sep. 30, 2019   6,225,719 6,786,896 3,688,740        
Ending balance at Sep. 30, 2019   $ 24,967 $ 55,151 $ 37,692        
Ending balance, shares at Sep. 30, 2019           4,038,239    
Beginning balance at Mar. 31, 2019 (71,113)         $ 6 1,625 (72,744)
Beginning balance, shares at Mar. 31, 2019   6,225,719 6,786,896 3,688,740        
Beginning balance at Mar. 31, 2019   $ 24,967 $ 55,151 $ 37,692        
Beginning balance, shares at Mar. 31, 2019           3,757,403    
Exercise of stock options 2           2  
Exercise of stock options (in shares)           889    
Vesting of early exercised stock options 20           20  
Stock-based compensation expense 278           278  
Net loss (10,665)             (10,665)
Ending balance at Jun. 30, 2019 (81,478)         $ 6 1,925 (83,409)
Ending balance, shares at Jun. 30, 2019   6,225,719 6,786,896 3,688,740        
Ending balance at Jun. 30, 2019   $ 24,967 $ 55,151 $ 37,692        
Ending balance, shares at Jun. 30, 2019           3,758,292    
Exercise of stock options $ 314         $ 1 313  
Exercise of stock options (in shares) 279,947         220,671    
Issuance of common stock related to early exercised stock options           59,276    
Vesting of early exercised stock options $ 55           55  
Stock-based compensation expense 266           266  
Net loss (11,317)             (11,317)
Ending balance at Sep. 30, 2019 (92,160)         $ 7 2,559 (94,726)
Ending balance, shares at Sep. 30, 2019   6,225,719 6,786,896 3,688,740        
Ending balance at Sep. 30, 2019   $ 24,967 $ 55,151 $ 37,692        
Ending balance, shares at Sep. 30, 2019           4,038,239    
Beginning balance at Dec. 31, 2019 $ (106,373)         $ 7 2,967 (109,347)
Beginning balance, shares at Dec. 31, 2019 20,390,095 6,225,719 6,786,896 7,377,480        
Beginning balance at Dec. 31, 2019 $ 160,310 $ 24,967 $ 55,151 $ 80,192        
Beginning balance, shares at Dec. 31, 2019           4,059,909    
Exercise of stock options 49           49  
Exercise of stock options (in shares)           28,837    
Issuance of common stock related to early exercised stock options           14,819    
Vesting of early exercised stock options 128           128  
Issuance of preferred stock         $ 109,875      
Issuance of preferred stock, net of issuance cost (in shares)         8,220,242      
Stock-based compensation expense 372           372  
Net loss (27,142)             (27,142)
Ending balance at Mar. 31, 2020 (132,966)         $ 7 3,516 (136,489)
Ending balance, shares at Mar. 31, 2020   6,225,719 6,786,896 7,377,480 8,220,242      
Ending balance at Mar. 31, 2020   $ 24,967 $ 55,151 $ 80,192 $ 109,875      
Ending balance, shares at Mar. 31, 2020           4,103,565    
Beginning balance at Dec. 31, 2019 $ (106,373)         $ 7 2,967 (109,347)
Beginning balance, shares at Dec. 31, 2019 20,390,095 6,225,719 6,786,896 7,377,480        
Beginning balance at Dec. 31, 2019 $ 160,310 $ 24,967 $ 55,151 $ 80,192        
Beginning balance, shares at Dec. 31, 2019           4,059,909    
Exercise of stock options (in shares) 263,626              
Net loss $ (68,480)              
Ending balance at Sep. 30, 2020 364,075         $ 54 541,848 (177,827)
Ending balance, shares at Sep. 30, 2020   0 0 0        
Ending balance, shares at Sep. 30, 2020           50,949,490    
Beginning balance at Mar. 31, 2020 (132,966)         $ 7 3,516 (136,489)
Beginning balance, shares at Mar. 31, 2020   6,225,719 6,786,896 7,377,480 8,220,242      
Beginning balance at Mar. 31, 2020   $ 24,967 $ 55,151 $ 80,192 $ 109,875      
Beginning balance, shares at Mar. 31, 2020           4,103,565    
Conversion of preferred stock 270,190 $ (24,967) $ (55,151) $ (80,192) $ (109,879) $ 29 270,161  
Conversion of preferred stock (in shares)   (6,225,719) (6,786,896) (7,377,480) (8,220,242)      
Conversion of preferred stock (in shares)           28,610,337    
Conversion of common stock warrant           30,278    
Conversion of preferred stock warrant           16,591    
Warrant liability write-off 629           629  
Issuance of common stock upon initial public offering, net of issuance costs of $3,296 264,079         $ 18 264,061  
Issuance of common stock upon initial public offering, net of issuance cost (in shares)           17,968,750    
Exercise of stock options 297           297  
Exercise of stock options (in shares)           152,177    
Vesting of early exercised stock options 12           12  
Issuance of preferred stock         $ 4      
Issuance costs for initial public offering           $ (3,296)    
Stock-based compensation expense 1,289           1,289  
Net loss (20,320)             (20,320)
Ending balance at Jun. 30, 2020 383,210         $ 54 539,965 (156,809)
Ending balance, shares at Jun. 30, 2020           50,881,698    
Exercise of stock options $ 108           108  
Exercise of stock options (in shares) 67,792         67,792    
Vesting of early exercised stock options $ 9           9  
Issuance costs for initial public offering (72)           (72)  
Stock-based compensation expense 1,838           1,838  
Net loss (21,018)             (21,018)
Ending balance at Sep. 30, 2020 $ 364,075         $ 54 $ 541,848 $ (177,827)
Ending balance, shares at Sep. 30, 2020   0 0 0        
Ending balance, shares at Sep. 30, 2020           50,949,490